Table:
IRD patient numbers	Patient origin (predominant)	NGS technology	Pathogenic/likely pathogenic mutations (%)	Reference
100	Dutch	Target capture 111 genes	∼ 50%	Neveling et al. 2012 (10)
20	France	Target capture 254 genes	57%	Audo et al. 2012 (11)
50	UK	Target capture 105 genes	50-50%	O’Sullivan et al. 2012 (12)
50	UK	Target capture 73 genes	53% (early onset IRD;25% overall)	Shanks et al. 2013 (13)
192	US	Target capture (GEDi) 214 genes	51%	Consugar et al. 2015 (14)
105	eyeGENE® database	Target capture 195 genes	49.5%	Ge et al. 2015 (15)
82	N Ireland	Target capture 186 genes	60%	Zhao et al. 2015 (16)
88	Italy	Target capture 72 genes	59.1%	Bernardis et al. 2016 (17)
309	Ireland	Target capture 216 genes	57%	Carrigan et al. 2016 (18)
537	Worldwide	Target capture 105 genes	51%	Ellingford et al. 2016 (19)
47	Spain	Target capture 75 genes	57.4%	Perez-Carro et al. 2016 (20)
88	European	Target capture & WES	61%	Weisschuh et al. 2016 (21)
58	Swiss	WES	64%	Tiwari et al. 2016 (22)
33	Mixed	WES	55%	de Castro-Miró et al. 2016 (23)
59	Spain	WES	71.8%	Riera et al. 2017 (24)
266	Dutch	Target panel & WES	52%	Haer-Wigman et al. 2017 (25)

Parse the image content behind with markdown code: | IRD patient numbers | Patient origin (predominant) | NGS technology | Pathogenic/likely pathogenic mutations (%) | Reference | 
 | --- | --- | --- | --- | --- | 
 | 100 | Dutch | Target capture 111 genes | ∼ 50% | Neveling et al. 2012 (10) | 
 | 20 | France | Target capture 254 genes | 57% | Audo et al. 2012 (11) | 
 | 50 | UK | Target capture 105 genes | 50-50% | O’Sullivan et al. 2012 (12) | 
 | 50 | UK | Target capture 73 genes | 53% (early onset IRD;25% overall) | Shanks et al. 2013 (13)

| 
 | 192 | US | Target capture (GEDi) 214 genes | 51% | Consugar et al. 2015 (14) | 
 | 105 | eyeGENE® database | Target capture 195 genes | 49.5% | Ge et al. 2015 (15) | 
 | 82 | N Ireland | Target capture 186 genes | 60% | Zhao et al. 2015 (16) | 
 | 88 | Italy | Target capture 72 genes | 59.1% | Bernardis et al. 2016 (17) | 
 | 309 | Ireland | Target capture 216 genes | 57% | Carrigan et al. 2016 (18) | 
 | 537 | Worldwide | Target capture 105 genes | 51% | Ellingford et al. 2016 (19) | 
 | 47 | Spain | Target capture 75 genes | 57.4% | Perez-Carro et al. 2016 (20) | 
 | 88 | European | Target capture & WES | 61% | Weisschuh et al. 2016 (21) | 
 | 58 | Swiss | WES | 64% | Tiwari et al. 2016 (22) | 
 | 33 | Mixed | WES | 55% | de Castro-Miró et al. 2016 (23) | 
 | 59 | Spain | WES | 71.8% | Riera et al. 2017 (24) | 
 | 266 | Dutch | Target panel & WES | 52% | Haer-Wigman et al. 2017 (25) |